Based on the forecasted data, the use of antihypertensive medicine in the UK is projected to decrease steadily over the next five years. The daily use per thousand persons is expected to drop from 13.7 units in 2024 to 13.5 units by 2028. The year-on-year percentage variations are calculated as follows:
- 2025: -0.73%
- 2026: 0.00%
- 2027: -0.74%
- 2028: 0.00%
The Compound Annual Growth Rate (CAGR) over the five-year forecast period is approximately -0.37%.
Future trends to watch for include potential impacts of new healthcare policies, advancements in alternative treatments, and changes in public health strategies focusing on hypertension prevention. These factors could significantly influence the projections and actual use of antihypertensive medicines.
